Management of Postpartum Hemorrhage
Oxytocin is the first-line pharmacological treatment for postpartum hemorrhage (PPH), followed by tranexamic acid (TXA), which should be administered within 3 hours of birth for all women with clinically diagnosed PPH. 1
Definition and Diagnosis
- PPH is defined as blood loss >500 mL after vaginal delivery or >1000 mL after cesarean section 1
- Primary PPH occurs within 24 hours of delivery; secondary PPH occurs between 24 hours and 6 weeks postpartum 1
- Objective measurement techniques (volumetric and gravimetric) should be used instead of visual estimation, which is notoriously inaccurate 1
Causes of PPH (Four T's)
- Tone (70-80% of cases): Uterine atony
- Trauma: Lacerations, hematomas, uterine inversion, uterine rupture
- Tissue: Retained placental tissue, placenta accreta spectrum disorders
- Thrombin: Coagulopathies 1, 2
Management Algorithm
First-Line Interventions
Uterine massage and bimanual compression
Oxytocin: First-line pharmacological treatment 1
- Initial IV bolus followed by infusion
- Higher doses (80 IU/500 mL over 1-4 hours) may be more effective than lower doses (10-30 IU) in preventing PPH 3
Tranexamic acid (TXA):
- Administer 1g IV over 10 minutes within 3 hours of birth
- Give second dose if bleeding continues after 30 minutes 1
Second-Line Interventions (if bleeding persists)
Additional uterotonics:
- Methergine (ergometrine): For routine management after delivery of placenta; postpartum atony and hemorrhage 4
- Carboprost tromethamine (Hemabate): For treatment of PPH due to uterine atony that hasn't responded to conventional management including IV oxytocin, uterine massage, and ergot preparations 5
- Misoprostol: Alternative if other uterotonics unavailable 1
Intrauterine balloon tamponade if pharmacological management fails 1
Third-Line Interventions
Surgical interventions:
Interventional radiology:
- Arterial embolization if patient is hemodynamically stable and facilities available 1
Blood Product Management
- Target hemoglobin >8 g/dL
- Maintain fibrinogen levels >2 g/L (hypofibrinogenemia is most predictive of severe PPH) 1
- If ongoing bleeding after 4 units of RBC, give 4 units of FFP and maintain 1:1 ratio until coagulation results available 1
- Consider cryoprecipitate or fibrinogen concentrate if fibrinogen <2 g/L 1
Monitoring and Supportive Care
- Continuous assessment of vital signs and blood loss
- Administer oxygen in severe PPH
- Prevent hypothermia (maintain body temperature >36°C) as clotting factors function poorly at lower temperatures 1
- Use crystalloid fluids for initial volume replacement 1
Prevention Strategies
- Active management of the third stage of labor:
- Oxytocin administration after delivery of anterior shoulder (most important component)
- Controlled cord traction
- Uterine massage after placental delivery 2
- Avoid routine episiotomy to decrease blood loss 2
- Identify high-risk patients (previous PPH, advanced maternal age, prolonged labor, pre-eclampsia, obesity, multiple pregnancy, macrosomia) 7
Common Pitfalls and Caveats
- Delayed recognition: Objective measurement of blood loss is essential as visual estimation often underestimates actual loss
- Focusing only on uterine atony: Remember to systematically evaluate for all causes (Four T's)
- Delayed TXA administration: Must be given within 3 hours of birth for maximum benefit
- Inadequate team response: Rapid team-based care minimizes morbidity and mortality
- Overlooking coagulopathy: Monitor and correct fibrinogen levels promptly
Early recognition, systematic evaluation of causes, and prompt escalation of interventions following a structured approach are crucial for successful management of PPH and prevention of maternal morbidity and mortality.